buthionine sulfoximine has been researched along with bucladesine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvero-Jackson, H; Benathan, M; Frenk, E; Mooy, AM; Scaletta, C | 1 |
| Chen, HL; Liao, TS; Lin, WM; Liu, CL; Sun, KH; Tsai, CY; Yu, CL; Yu, HS | 1 |
| Bánhegyi, G; Braun, L; Csala, M; Garzó, T; Mandl, J; Poussu, A | 1 |
| Pentreath, VW; Slamon, ND | 1 |
| Butler, J; Pentreath, VW; Slamon, ND; Ward, TH | 1 |
| Greenberg, DA; Jin, K; Kim, SH; Mao, XO; Won, SJ | 1 |
6 other study(ies) available for buthionine sulfoximine and bucladesine
| Article | Year |
|---|---|
Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
Topics: Bucladesine; Buthionine Sulfoximine; Cell Differentiation; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Eye Neoplasms; Glutathione; Glutathione Transferase; Humans; Kinetics; Melanins; Melanoma; Melphalan; Methionine Sulfoximine; Microscopy, Electron; Monophenol Monooxygenase; Neoplasm Staging; Skin Neoplasms; Tumor Cells, Cultured | 1992 |
Prostaglandin E2 suppresses phytohemagglutinin-induced immune responses of normal human mononuclear cells by decreasing intracellular glutathione generation, but not due to increased DNA strand breaks or apoptosis.
Topics: Antimetabolites; Apoptosis; Bucladesine; Buthionine Sulfoximine; CD4-CD8 Ratio; Cell Cycle; Dinoprostone; DNA Damage; Enzyme-Linked Immunosorbent Assay; Glutathione; Humans; Immunity, Cellular; In Vitro Techniques; Lymphocyte Activation; Methionine Sulfoximine; Monocytes; Phytohemagglutinins; Receptors, Interleukin-2; Thymidine | 1993 |
Glutathione depletion induces glycogenolysis dependent ascorbate synthesis in isolated murine hepatocytes.
Topics: Acetaminophen; Animals; Ascorbic Acid; Bucladesine; Buthionine Sulfoximine; Cyclic AMP; Diamide; Fructose; Glutathione; Glycogen; Liver; Male; Methionine Sulfoximine; Mice; Sugar Acids; Uridine Diphosphate Glucose; Vitamin K | 1996 |
Antioxidant defense against antidepressants in C6 and 1321N1 cells.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Animals; Antidepressive Agents; Antimetabolites; Antioxidants; Astrocytes; Astrocytoma; Bucladesine; Buthionine Sulfoximine; Cyclic AMP; Drug Interactions; Glioma; Glutathione; Humans; Isoproterenol; Neuroprotective Agents; Oxidative Stress; Phosphodiesterase Inhibitors; Rats; Tumor Cells, Cultured | 2000 |
Assessment of DNA damage in C6 glioma cells after antidepressant treatment using an alkaline comet assay.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bucladesine; Buthionine Sulfoximine; Comet Assay; DNA Damage; Enzyme Inhibitors; Glioma; Glutathione; Phosphodiesterase Inhibitors; Rats; Tumor Cells, Cultured | 2001 |
Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury.
Topics: Animals; Antimetabolites; Antioxidants; Benzoxazines; Bucladesine; Buthionine Sulfoximine; Cannabinoids; Cell Death; Cells, Cultured; Chlorides; Cyclic AMP-Dependent Protein Kinases; Ferric Compounds; Immunohistochemistry; L-Lactate Dehydrogenase; Mice; Mice, Knockout; Morpholines; Naphthalenes; Neurons; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant | 2005 |